K839-0034 Screening compound: N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide

K839-0034 Screening compound: N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide
K839-0034 Screening compound: N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound K839-0034
N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K839-0034

Molecular Formula

C25H20N2O4 (C25 H20 N2 O4)

Compound Name

N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide

IUPAC name

N-[(2-hydroxynaphthalen-1-yl)(3-nitrophenyl)methyl]-2-phenylacetamide

SMILES

[O-][N+](c1cc(C(c(c2ccccc2cc2)c2O)NC(Cc2ccccc2)=O)ccc1)=O

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

412.44

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.782

Distribution Coefficient, logD

4.668

Water Solubility, LogSw

-5.52

Polar Surface Area

73.177

Acid Dissociation Constant (pKa)

7.92

Base Dissociation Constant (pKb)

-4.02

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

8.00

K839-0034 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

DGK Inhibitors Library (10558 compounds)

Glucocorticoid receptors Library (4806 compounds)

Hsp90-Targeted Library (11355 compounds)

PLpro Library (6343 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
  • Nuclear receptors
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with K839-0034 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K839-0034?
Check Price and Availability of K839-0034, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K839-0034 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K839-0034
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K839-0034
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K839-0034 available by request